Cerebiome®Updated 2 days ago
What is Cerebiome®—and why is it in Biotic⁺?
Cerebiome® is a clinically studied blend of probiotic strains that supports both gut health and mental wellbeing. It’s part of a growing field of “psychobiotics”—live bacteria that work through the gut-brain axis to help you feel calmer, more resilient, and emotionally balanced.
Included in Biotic⁺ at a clinically relevant dose, it contains:
Lactobacillus helveticus Rosell-52
Bifidobacterium longum Rosell-175
In human clinical trials this blend of strains has been shown to:
Reduce general stress levels by 44% (Messaoudi et al., 2010)
Support healthy mood, brain function, and emotional wellbeing
Improve gut comfort in times of stress (Diop et al., 2008)
Help regulate cortisol, the body’s stress hormone (Messaoudi et al., 2010)
Support serotonin and tryptophan pathways
🤔 What makes Cerebiome® unique?
Cerebiome® is a best-in-class probiotic with more than a decade of research and real-world use. It’s:
Clinically proven for stress and mood support
Made from live probiotic bacteria, with a well-established safety profile
Stable at room temperature—no refrigeration needed
Compliant with standards set by EFSA, WHO, FDA, and others
It’s included in Biotic⁺ for its unique ability to support both your gut and your mind—naturally, and without side effects.
🤔 How does Cerebiome® work?
It works through the microbiome-gut-brain axis—the communication link between your digestive system and your brain.
Cerebiome® helps to:
Promote a balanced gut microbiome
Strengthen the intestinal barrier
Support neurotransmitter regulation, like serotonin
Improve your response to stress—from the inside out
🔎 Want to learn more? Check out this short video
📚 References:
Diop et al. (2008). “Probiotic food supplement reduces stress-induced gastrointestinal symptoms in volunteers: a double-blind, placebo-controlled, randomized trial.” Nutrition Research 28(1): 1-5.
Messaoudi et al. (2011). Assessment of psychotropic-like properties of a probiotic formulation (Lactobacillus helveticus R0052 and Bifidobacterium longum R0175) in rats and human subjects. British Journal of Nutrition, 105(5), 755-764.
Kazemi, A., et al. (2018). “Effect of probiotic and prebiotic vs placebo on psychological outcomes in patients with major depressive disorder: A randomized clinical trial.” Clinical Nutrition
Romijn, A. R., et al. (2017). “A double-blind, randomized, placebo-controlled trial of Lactobacillus helveticus and Bifidobacterium longum for the symptoms of depression.” Australian & New Zealand Journal of Psychiatry: 0004867416686694.
Wallace, C. J. K., & Milev, R. V. (2021). The Efficacy, Safety, and Tolerability of Probiotics on Depression: Clinical Results From an Open-Label Pilot Study. Frontiers in Psychiatry, 12.